| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTR1B
|
ARP1 actin-related protein 1 homolog B, centractin beta (yeast)
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
APCS
|
amyloid P component, serum
|
|
API5
|
apoptosis inhibitor 5
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
ARG2
|
arginase 2
|
|
B2M
|
beta-2-microglobulin
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BCL2L1
|
BCL2-like 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTLA
|
B and T lymphocyte associated
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
CALR
|
calreticulin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD19
|
CD19 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD70
|
CD70 molecule
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
CRYGD
|
crystallin, gamma D
|
|
CTSG
|
cathepsin G
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha)
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EPHA2
|
EPH receptor A2
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLG2
|
filaggrin family member 2
|
|
FN1
|
fibronectin 1
|
|
FOXP3
|
forkhead box P3
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GDF15
|
growth differentiation factor 15
|
|
GMDS
|
GDP-mannose 4,6-dehydratase
|
|
GRP
|
gastrin-releasing peptide
|
|
GSN
|
gelsolin
|
|
H2AFY
|
H2A histone family, member Y
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HP
|
haptoglobin
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
JAK1
|
Janus kinase 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LRRC3B
|
leucine rich repeat containing 3B
|
|
MAX
|
MYC associated factor X
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR10B
|
microRNA 10b
|
|
MIR148A
|
microRNA 148a
|
|
MIR210
|
microRNA 210
|
|
MIR376A1
|
microRNA 376a-1
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLH1
|
mutL homolog 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NOG
|
noggin
|
|
NOTCH3
|
notch 3
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PGAM4
|
phosphoglycerate mutase family member 4
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLD2
|
phospholipase D2
|
|
PLG
|
plasminogen
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAET1E
|
retinoic acid early transcript 1E
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
REN
|
renin
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF5
|
ring finger protein 5, E3 ubiquitin protein ligase
|
|
RORA
|
RAR-related orphan receptor A
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SEPN1
|
selenoprotein N, 1
|
|
SFN
|
stratifin
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMAD7
|
SMAD family member 7
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SRI
|
sorcin
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TCEA2
|
transcription elongation factor A (SII), 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TRIM5
|
tripartite motif containing 5
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULBP3
|
UL16 binding protein 3
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WT1
|
Wilms tumor 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|